Selvita enjoys strong growth in 2015

Krakow, Poland – March 23, 2016 – Selvita, the largest drug discovery company in Central and Eastern Europe, has reported another year of a double digit revenue growth.   In 2015, the company has enjoyed strong growth of revenues, which amounted to PLN 55.7 MM, compared to PLN 41.3 MM…

More

Selvita Bridges Krakow and San Francisco

San Bruno, CA – March 11, 2016 – Selvita, the largest drug discovery company in Central and Eastern Europe, has just opened its West Coast US office, located in San Bruno, CA. Selvita has initiated its US operations in September 2015, opening a fully-owned US subsidiary, Selvita Inc., headquartered in…

More

Selvita opens new research site in Poznan

Krakow, Poland – 4 February 2016 – Selvita (WSE:SLV), the largest drug discovery company in Central and Eastern Europe, has signed a contract for the lease of laboratory space in Poznan, Poland. The new site will be located at in the Wielkopolska Centre of Advanced Technologies and commence research activities…

More

Selvita will present at the 18th Annual BIO CEO & Investor Conference 2016

Krakow, 1 February 2016 – Selvita S.A. (WSE: SLV), the largest drug discovery company in Central and Eastern Europe, today announced that Pawel Przewiezlikowski, Chief Executive Officer of the company, will present at the upcoming 18th Annual BIO CEO & Investor Conference, which will take place on February 8 –…

More

Selvita joins the European network of laboratories EU NETVAL

Krakow, December 15, 2015 – Selvita, the largest drug discovery company in Central and Eastern Europe, announced today that its Cell and Molecular Biology Laboratory has been incorporated into the European network of laboratories EU NETVAL (European Union Network of Laboratories for the Validation of Alternative Methods; https://eurl-ecvam.jrc.ec.europa.eu/eu-netval ).  …

More

...89101112...